Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation?

Laliberte Francois; Pilon Dominic; Raut Monika K.; Nelson Winnie W.; Olson William H.; Germain Guillaume; Schein Jeff R.; Lefebvre Patrick

首页> 外文期刊>Current medical research and opinion >Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation?

【24h】

Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation?

机译：在非瓣膜性房颤患者中，利伐沙班与华法林相比的住院费用是否较低？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:

机译：背景：

著录项

来源
《Current medical research and opinion》 |2014年第8期|共8页
作者
Laliberte Francois; Pilon Dominic; Raut Monika K.; Nelson Winnie W.; Olson William H.; Germain Guillaume; Schein Jeff R.; Lefebvre Patrick;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词
Anticoagulant agents; Atrial fibrillation; Healthcare costs; Rivaroxaban; Warfarin;

机译：抗凝剂;心房纤颤;卫生保健费用;利伐沙班;华法林;

相似文献

外文文献
中文文献
专利

1. Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation? [J] . Laliberte Francois, Pilon Dominic, Raut Monika K., Current medical research and opinion . 2014,第8期

机译：在非瓣膜性房颤患者中，利伐沙班与华法林相比的住院费用是否较低？
2. Hospital length of stay: is rivaroxaban associated with shorter inpatient stay compared to warfarin among patients with non-valvular atrial fibrillation? [J] . Fran?ois Laliberté, Dominic Pilon, Monika K Raut, Current medical research and opinion . 2014,第4期

机译：医院住宿时间：与非瓣膜心房颤动患者的Warfarin相比，与较短的住院患者留下的rivaroxaban有关吗？
3. Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare population [J] . Amin Alpesh, Keshishian Allison, Trocio Jeffrey, Current medical research and opinion . 2017,第9期

机译：与美国医疗保险人口的华法林相比，中风/全身栓塞患者的中风/全身栓塞患者的严重出血和相关成本
4. Group-Based Trajectory Analysis for Long-Term Use of Warfarin Therapy in Atrial Fibrillation Patients [C] . Shijing Guo, Xiang Li, Xin Du, MEDINFO . 2017

机译：基于组的术语轨迹分析，用于高级患者的华法林治疗
5. Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for the prevention of stroke prophylaxis in atrial fibrillation. [D] . Harrington, Amanda. 2012

机译：阿哌沙班，达比加群，利伐沙班和华法林预防房颤预防中风的成本效益。
6. Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users [O] . François Laliberté, Michel Cloutier, Concetta Crivera, -1

机译：利伐沙班和华法林对非瓣膜性房颤患者医疗保健费用的影响：利伐沙班使用者和配套的华法林使用者的观察
7. PCV4 Hospital Length Of Stay: Does Rivaroxaban Reduce Inpatient Stay Compared To Warfarin Among Patients With Non-Valvular Atrial Fibrillation? [O] . Laliberté F., Pilon D., Raut M., 2014

机译：PCV4医院住院时间：在非瓣膜性房颤患者中，利伐沙班与华法林相比是否能减少住院时间？

Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation?

摘要

著录项

相似文献

相关主题

期刊订阅